{"id":"https://openalex.org/W4394807705","doi":"https://doi.org/10.1038/s43018-024-00767-4","title":"Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction","display_name":"Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction","publication_year":2024,"publication_date":"2024-04-15","ids":{"openalex":"https://openalex.org/W4394807705","doi":"https://doi.org/10.1038/s43018-024-00767-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/38622449"},"language":"en","primary_location":{"id":"doi:10.1038/s43018-024-00767-4","doi":"https://doi.org/10.1038/s43018-024-00767-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s43018-024-00767-4","pdf_url":"https://www.nature.com/articles/s43018-024-00767-4.pdf","source":{"id":"https://openalex.org/S4210236562","display_name":"Nature Cancer","issn_l":"2662-1347","issn":["2662-1347"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Cancer","raw_type":"journal-article"},"volume":null,"type":"erratum","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nature.com/articles/s43018-024-00767-4.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056138191","display_name":"Hugh O\u2019Brien","orcid":"https://orcid.org/0000-0002-6829-5306","observed_orcids":["https://orcid.org/0000-0002-6829-5306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugh O\u2019Brien","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-6829-5306","affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075621794","display_name":"Max Salm","orcid":"https://orcid.org/0000-0002-5742-3376","observed_orcids":["https://orcid.org/0000-0002-5742-3376"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Max Salm","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK. m.salm@achillestx.com","Achilles Therapeutics Ltd, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK. m.salm@achillestx.com","institution_ids":[]},{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029149334","display_name":"Laura T. Morton","orcid":"https://orcid.org/0000-0003-3222-8926","observed_orcids":["https://orcid.org/0000-0003-3222-8926"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura T. Morton","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033594406","display_name":"Maciej J. Szukszto","orcid":"https://orcid.org/0000-0002-0463-652X","observed_orcids":["https://orcid.org/0000-0002-0463-652X"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maciej Szukszto","raw_affiliation_strings":["Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-0463-652X","affiliations":[{"raw_affiliation_string":"Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036919914","display_name":"Felix O\u2019Farrell","orcid":"https://orcid.org/0009-0008-4942-4230","observed_orcids":["https://orcid.org/0009-0008-4942-4230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felix O\u2019Farrell","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023604038","display_name":"Charlotte Boulton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Boulton","raw_affiliation_strings":["Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076631069","display_name":"Pablo Daniel Becker","orcid":"https://orcid.org/0000-0003-1980-1230","observed_orcids":["https://orcid.org/0000-0003-1980-1230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pablo D. Becker","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042139239","display_name":"Yardena Samuels","orcid":"https://orcid.org/0000-0002-3349-7266","observed_orcids":["https://orcid.org/0000-0002-3349-7266"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Yardena Samuels","raw_affiliation_strings":["Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":"https://orcid.org/0000-0002-3349-7266","affiliations":[{"raw_affiliation_string":"Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016475369","display_name":"Charles Swanton","orcid":"https://orcid.org/0000-0002-4299-3018","observed_orcids":["https://orcid.org/0000-0002-4299-3018"]},"institutions":[{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charles Swanton","raw_affiliation_strings":["The Francis Crick Institute, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-4299-3018","affiliations":[{"raw_affiliation_string":"The Francis Crick Institute, London, UK","institution_ids":["https://openalex.org/I2801081054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074584714","display_name":"Marc R. Mansour","orcid":"https://orcid.org/0000-0001-6835-3791","observed_orcids":["https://orcid.org/0000-0001-6835-3791","https://orcid.org/0000-0002-7449-845X"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marc R. Mansour","raw_affiliation_strings":["Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK"],"raw_orcid":"https://orcid.org/0000-0001-6835-3791","affiliations":[{"raw_affiliation_string":"Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033440492","display_name":"Sine Reker Hadrup","orcid":"https://orcid.org/0000-0002-5937-4344","observed_orcids":["https://orcid.org/0000-0002-5937-4344"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Sine Reker Hadrup","raw_affiliation_strings":["Technical University of Denmark, Lyngby, Denmark. sirha@dtu.dk","Technical University of Denmark, Lyngby, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Technical University of Denmark, Lyngby, Denmark. sirha@dtu.dk","institution_ids":["https://openalex.org/I96673099"]},{"raw_affiliation_string":"Technical University of Denmark, Lyngby, Denmark","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012617779","display_name":"Sergio A. Quezada","orcid":"https://orcid.org/0000-0002-9763-1700","observed_orcids":["https://orcid.org/0000-0002-9763-1700"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Sergio A. Quezada","raw_affiliation_strings":["Achilles Therapeutics Ltd, London, UK. s.quezada@ucl.ac.uk","Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk","Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-9763-1700","affiliations":[{"raw_affiliation_string":"Achilles Therapeutics Ltd, London, UK. s.quezada@ucl.ac.uk","institution_ids":[]},{"raw_affiliation_string":"Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5012617779","https://openalex.org/A5033440492","https://openalex.org/A5075621794"],"corresponding_institution_ids":["https://openalex.org/I45129253","https://openalex.org/I96673099"],"apc_list":{"value":12290,"currency":"USD","value_usd":12290},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"4","first_page":"692","last_page":"692"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.19509999454021454,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.13230000436306,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8970000147819519},{"id":"https://openalex.org/keywords/immunogenicity-prediction","display_name":"immunogenicity prediction","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/author-name-correction","display_name":"author name correction","score":0.6740000247955322},{"id":"https://openalex.org/keywords/funding-acknowledgment","display_name":"funding acknowledgment","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8500596284866333},{"id":"https://openalex.org/C2777489069","wikidata":"https://www.wikidata.org/wiki/Q1589822","display_name":"Ceiling (cloud)","level":2,"score":0.7185220718383789},{"id":"https://openalex.org/C191290158","wikidata":"https://www.wikidata.org/wiki/Q14773596","display_name":"Ceiling effect","level":3,"score":0.44672828912734985},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4006463289260864},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.39116084575653076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26638951897621155},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20413312315940857},{"id":"https://openalex.org/C66938386","wikidata":"https://www.wikidata.org/wiki/Q633538","display_name":"Structural engineering","level":1,"score":0.18587514758110046},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1652955412864685},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.1491599977016449},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.11011937260627747},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06323692202568054},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1038/s43018-024-00767-4","doi":"https://doi.org/10.1038/s43018-024-00767-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s43018-024-00767-4","pdf_url":"https://www.nature.com/articles/s43018-024-00767-4.pdf","source":{"id":"https://openalex.org/S4210236562","display_name":"Nature Cancer","issn_l":"2662-1347","issn":["2662-1347"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Cancer","raw_type":"journal-article"},{"id":"pmid:38622449","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38622449","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature cancer","raw_type":"Published Erratum"}],"best_oa_location":{"id":"doi:10.1038/s43018-024-00767-4","doi":"https://doi.org/10.1038/s43018-024-00767-4","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s43018-024-00767-4","pdf_url":"https://www.nature.com/articles/s43018-024-00767-4.pdf","source":{"id":"https://openalex.org/S4210236562","display_name":"Nature Cancer","issn_l":"2662-1347","issn":["2662-1347"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4394807705.pdf","grobid_xml":"https://content.openalex.org/works/W4394807705.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389780814","https://openalex.org/W4214817103","https://openalex.org/W4236294751","https://openalex.org/W2755102409","https://openalex.org/W7025205037","https://openalex.org/W6906829090","https://openalex.org/W3042758023","https://openalex.org/W6912756699","https://openalex.org/W4408164218","https://openalex.org/W4388673769"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-04-16T00:00:00"}